Division of life Science and Medicine, Department of Gastrointestinal Surgery, The First Affiliated Hospital of USTC (Anhui Provincial Tumor Hospital), University of Science and Technology of China, Hefei, Anhui, P.R., China
Case Report
Conversion Therapy for Advanced Gastric Cancer with Apa-tinib Combined with SOX Regimen: A Report of Two Cases and Literature Review
Author(s): Jun Zhang, Yan Dai and Zhongliang Ning*
In late state gastric cancer, combination chemotherapy with targeted therapy has been employed, which may control the tumor growth and recurrence. We here report two patients diagnosed with advanced gastric cancer which were treated with SOX regimen combined with apatinib for conversion therapy. After three cycles of this combination treatment, the lymph node metastases and tumor decreased in size, which enabled the surgery (R0 resection), with no recurrence for more than 1 year. We believe that apatinib combined with SOX regimen can increase the possibility of successful surgical resection, and thereby prolonging the progression-free survival of patients with advanced gastric cancer.. Read More»
Journal of Clinical Case Reports received 1345 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 